Associations Between Low-Value Medication in Dementia and Healthcare Costs

ConclusionLvm were prevalent, more likely occurring in the early stages of dementia, and cause financial harm for payers due to higher direct medical care costs. Further research is required to derive measures to prevent cost-driving Lvm in primary care, that is, implementing deprescribing interventions and moving health expenditures towards higher value resource use.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research